LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free PRTC Stock Alerts GBX 225 +2.00 (+0.90%) (As of 03/27/2024 09:27 PM ET) Add Compare Share Share Today's Range 221▼ 229.5050-Day Range 181▼ 22952-Week Range 139▼ 242.93Volume150,805 shsAverage Volume413,450 shsMarket Capitalization£607.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get PureTech Health alerts: Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About PureTech Health Stock (LON:PRTC)PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesMarch 22, 2024 | thestreet.comPureTech Health plcMarch 19, 2024 | msn.comPureTech announces $100M capital return through tender offerMarch 28, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.February 28, 2024 | finance.yahoo.comAKLI Mar 2024 1.000 callFebruary 8, 2024 | msn.com2 impressive growth stocks I’ve got my eye on in FebruaryNovember 17, 2023 | finance.yahoo.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 14, 2023 | lse.co.ukPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | finance.yahoo.comPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersMarch 28, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.August 29, 2023 | finanznachrichten.dePureTech Health plc - Half-Year ReportAugust 1, 2023 | msn.comPureTech bags $11.4M from U.S. Department of Defense contractAugust 1, 2023 | finance.yahoo.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeJune 21, 2023 | lse.co.ukPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | finance.yahoo.comPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersApril 29, 2023 | benzinga.comPureTech Health Stock (NASDAQ:PRTC), DividendsApril 28, 2023 | markets.businessinsider.comPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The DetailsApril 25, 2023 | bizjournals.comMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsApril 25, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesApril 20, 2023 | lse.co.ukPureTech Health's Vedanta Biosciences boasts "promising" resultsMarch 23, 2023 | proactiveinvestors.comPureTech Health remains undervalued after KarXCT deal, says brokerMarch 23, 2023 | marketwatch.comPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty DealMarch 23, 2023 | markets.businessinsider.comRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTMarch 23, 2023 | proactiveinvestors.comPureTech Health shares jump 10% on US$500mln royalty dealMarch 23, 2023 | finance.yahoo.comRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionFebruary 27, 2023 | finance.yahoo.comPureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)December 19, 2022 | marketwatch.comPureTech Health's Depression Treatment Phase 1 Study Shows Positive DataDecember 13, 2022 | finance.yahoo.comPureTech to Present at 41st Annual J.P. Morgan Healthcare ConferenceSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CUSIPN/A CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-47,010,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-7.22% Return on Assets-14.24% Debt Debt-to-Equity Ratio25.41 Current Ratio7.31 Quick Ratio2.51 Sales & Book Value Annual Sales£11.74 million Price / Sales51.74 Cash FlowGBX 105.06 per share Price / Cash Flow2.14 Book ValueGBX 186 per share Price / Book1.21Miscellaneous Outstanding Shares269,950,000Free FloatN/AMarket Cap£607.39 million OptionableNot Optionable Beta0.94 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 47)Founder, CEO & Exec. Director Dr. Bennett M. Shapiro (Age 78)Co-Founder & Non-Exec. Director Dr. Robert S. Langer Jr. (Age 69)Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board Mr. Stephen M. Muniz J.D. (Age 48)COO, Exec. VP of Legal & Operations, Sec. and Exec. Director Dr. Bharatt M. Chowrira (Age 53)Pres and Chief of Bus. & Strategy Key CompetitorsErgomedLON:ERGOSilence TherapeuticsLON:SLNHorizon Discovery Group plc (HZD.L)LON:HZDBioventixLON:BVXPVerona Pharma plc (VRP.L)LON:VRPView All Competitors PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed in 2024? PureTech Health's stock was trading at GBX 194.20 at the beginning of 2024. Since then, PRTC shares have increased by 15.9% and is now trading at GBX 225. View the best growth stocks for 2024 here. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN), Chaarat Gold (CGH), Eldorado Gold (ELD), CarMax (KMX) and Knowles (KN). How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PRTC) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.